Challenge Theme – iPSCs

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Challenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processChallenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterPress Release: iPSC line licensed to Universal Cells to assist in the development of universal donor cell linePress Release: iPSC line licensed to Universal Cells to assist in the development of universal donor cell line